These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31094258)

  • 41. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
    von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
    J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
    Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
    Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 44. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells.
    Solbrig CM; Saucier-Sawyer JK; Cody V; Saltzman WM; Hanlon DJ
    Mol Pharm; 2007; 4(1):47-57. PubMed ID: 17217312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
    Salem ML
    Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.
    Kokhaei P; Choudhury A; Mahdian R; Lundin J; Moshfegh A; Osterborg A; Mellstedt H
    Leukemia; 2004 Nov; 18(11):1810-5. PubMed ID: 15385926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.
    Vegh Z; Mazumder A
    Cancer Immunol Immunother; 2003 Feb; 52(2):67-79. PubMed ID: 12594570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen.
    Saluja SS; Hanlon DJ; Sharp FA; Hong E; Khalil D; Robinson E; Tigelaar R; Fahmy TM; Edelson RL
    Int J Nanomedicine; 2014; 9():5231-46. PubMed ID: 25419128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells.
    Liu Y; Tian X; Jiang S; Ren X; Liu F; Yang J; Chen Y; Jiang Y
    Cell Immunol; 2015; 298(1-2):18-24. PubMed ID: 26300426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
    Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells.
    Mahdian R; Kokhaei P; Najar HM; Derkow K; Choudhury A; Mellstedt H
    Med Oncol; 2006; 23(2):273-82. PubMed ID: 16720928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Dendritic Cells-Targeting Nano-Vaccine by Coupling Polylactic-Co-Glycolic Acid-Encapsulated Allergen with Mannan Induces Regulatory T Cells.
    Wen H; Qu L; Zhang Y; Xu B; Ling S; Liu X; Luo Y; Huo D; Li W; Yao X
    Int Arch Allergy Immunol; 2021; 182(9):777-787. PubMed ID: 34289474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.
    Salem ML; Nassef M; Gomaa S; Essa I
    Biomed Pharmacother; 2017 Sep; 93():286-295. PubMed ID: 28648976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.
    Jahan ST; Sadat SM; Haddadi A
    Int J Nanomedicine; 2018; 13():367-386. PubMed ID: 29391795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells].
    Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective colorectal cancer cell lysates enhance the immune function of mature dendritic cells in vitro.
    Chen L; Meng D; Zhao L; Liu R; Bai P; Wang L; Xiao J
    Mol Med Rep; 2015 Mar; 11(3):1877-84. PubMed ID: 25394863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.